45
0
0
Like?
Please wait...
About This Project
Our immune T-cells are a type of white blood cell that are crucial to recognise and attack infections and cancerous cells. For this reason, T-cells are important drug targets in vaccines and cancer immunotherapies. A drug currently in pre-clinical development is showing promising results in boosting a key regulator in T-cell functions 500-fold, but how this happens remains a mystery. We hypothesise that the drug increases the active state of the T-cell regulator by inducing a structural change.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Urban Pollination: sustain native bees & urban crops
Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...
Cannibalism in Giant Tyrannosaurs
This is the key question we hope to answer with this study. This project is to fund research into a skull...
Seattle HiveBio Community Lab
Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...